Insight ReportDrugstore Decimation: Assessing Rite Aid’s Closures, and Which Competitors Stand To Gain Vaishnavi Nayak K, Analyst February 5, 2026 Reasons to ReadDiscover the key dynamics shaping the US drugstore sector and the strategic opportunities arising from Rite Aid’s closure. Read this report to discover answers to these and other questions: What impact will Rite Aid’s store closures have on CVS Health and Walgreens (Walgreen Co.)? How does CVS Health’s proximity to Rite Aid stores compare to that of Walgreen Co.? What geographical areas will be most affected by Rite Aid’s shutdown? Why are major drugstore chains closing stores and how will this shape the future of the sector? Companies mentioned in this report include: CVS Health, Walgreen Co. Data in this report include: store closures data, geographic proximity of stores, store estate analysis, market share potential, industry trends. Other relevant research: US Drugstore and Pharmacy Retailing: Themes, Concepts and Innovators—Rightsizing for Relevance; Smaller Footprints for a Bigger Impact US Drugstores and Pharmacies: Real Estate Insights—Closures Lead to 8 Million Square Feet of Shuttered Retail Space in 2024 Aldi vs. Lidl US Store Openings: Mapping Retail Real Estate Changes with the Store Intelligence Platform Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Weekly UK Store Openings and Closures Tracker 2025, Week 36: UK Sees 25% Fewer Closures Year Over YearEarnings Insights 4Q24, Week 7: Costco, Inditex and Puma Lead with Solid Fourth-Quarter GrowthUS CPG Sales Tracker: CPG E-Commerce Growth Eases from Prime Day Peak; General Merchandise Decline Confirms Pull-Forward EffectTransforming Beauty Retail: AI Across the Value Chain, from Innovation to Personalization
